NO322359B1 - 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler - Google Patents

1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler Download PDF

Info

Publication number
NO322359B1
NO322359B1 NO20022044A NO20022044A NO322359B1 NO 322359 B1 NO322359 B1 NO 322359B1 NO 20022044 A NO20022044 A NO 20022044A NO 20022044 A NO20022044 A NO 20022044A NO 322359 B1 NO322359 B1 NO 322359B1
Authority
NO
Norway
Prior art keywords
compound
cyclic amino
compounds
alkylcyclohexane
amino
Prior art date
Application number
NO20022044A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022044D0 (no
NO20022044L (no
Inventor
Wojciech Danysz
Markus Gold
Ivars Kalvinsh
Christopher Graham Rap Parsons
Valerjans Kauss
Aigars Jirgensons
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of NO20022044D0 publication Critical patent/NO20022044D0/no
Publication of NO20022044L publication Critical patent/NO20022044L/no
Publication of NO322359B1 publication Critical patent/NO322359B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20022044A 1999-11-01 2002-04-30 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler NO322359B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/008317 WO2001032640A1 (en) 1999-11-01 1999-11-01 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants

Publications (3)

Publication Number Publication Date
NO20022044D0 NO20022044D0 (no) 2002-04-30
NO20022044L NO20022044L (no) 2002-04-30
NO322359B1 true NO322359B1 (no) 2006-09-18

Family

ID=8167482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022044A NO322359B1 (no) 1999-11-01 2002-04-30 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler

Country Status (24)

Country Link
EP (1) EP1228052B1 (pl)
JP (1) JP4043236B2 (pl)
KR (1) KR100548600B1 (pl)
CN (1) CN1264827C (pl)
AT (1) ATE361284T1 (pl)
AU (1) AU782760B2 (pl)
CA (1) CA2389325C (pl)
CY (1) CY1106672T1 (pl)
CZ (1) CZ20021533A3 (pl)
DE (1) DE69936004T2 (pl)
DK (1) DK1228052T3 (pl)
EA (1) EA005684B1 (pl)
ES (1) ES2285870T3 (pl)
HK (1) HK1049160B (pl)
HU (1) HUP0203275A3 (pl)
IL (2) IL149401A0 (pl)
MX (1) MXPA02004368A (pl)
NO (1) NO322359B1 (pl)
PL (1) PL199587B1 (pl)
PT (1) PT1228052E (pl)
SI (1) SI1228052T1 (pl)
TW (1) TWI242547B (pl)
UA (1) UA72558C2 (pl)
WO (1) WO2001032640A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
CN104211663B (zh) * 2014-08-11 2017-01-11 杭州偶联医药科技有限公司 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
RU2714135C1 (ru) * 2019-11-22 2020-02-12 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097207A (en) * 1958-03-06 1963-07-09 Parke Davis & Co 1-halophenyl and 1-alkoxyphenyl cyclohexylamines
UA61962C2 (uk) * 1997-06-30 2003-12-15 Мерц Фарма Гмбх Унд Ко. Кгаа Сполука 1-аміноалкілциклогексану, фармацевтична композиція на її основі та спосіб лікування

Also Published As

Publication number Publication date
ATE361284T1 (de) 2007-05-15
CN1264827C (zh) 2006-07-19
IL149401A (en) 2008-03-20
KR100548600B1 (ko) 2006-02-01
AU1158500A (en) 2001-05-14
AU782760B2 (en) 2005-08-25
JP4043236B2 (ja) 2008-02-06
NO20022044D0 (no) 2002-04-30
CZ20021533A3 (cs) 2002-08-14
EP1228052A1 (en) 2002-08-07
ES2285870T3 (es) 2007-11-16
PT1228052E (pt) 2007-05-31
EP1228052B1 (en) 2007-05-02
HUP0203275A2 (hu) 2003-01-28
DE69936004D1 (de) 2007-06-14
DE69936004T2 (de) 2008-01-10
PL354519A1 (pl) 2004-01-26
NO20022044L (no) 2002-04-30
HK1049160B (zh) 2006-11-17
CA2389325C (en) 2007-01-09
IL149401A0 (en) 2002-11-10
HUP0203275A3 (en) 2003-11-28
TWI242547B (en) 2005-11-01
PL199587B1 (pl) 2008-10-31
HK1049160A1 (en) 2003-05-02
EA005684B1 (ru) 2005-04-28
SI1228052T1 (sl) 2007-10-31
KR20020063172A (ko) 2002-08-01
EA200200522A1 (ru) 2002-10-31
JP2003513083A (ja) 2003-04-08
WO2001032640A1 (en) 2001-05-10
CY1106672T1 (el) 2012-05-23
MXPA02004368A (es) 2002-11-14
CA2389325A1 (en) 2001-05-10
DK1228052T3 (da) 2007-06-18
UA72558C2 (uk) 2005-03-15
CN1374956A (zh) 2002-10-16

Similar Documents

Publication Publication Date Title
DE69425662T2 (de) Als heilmittel nutzbare piperazin verbindungen
KR101536023B1 (ko) 조합된 sert, 5-ht3 및 5-ht1a 활성을 가진 화합물의 치료 용도
NO321130B1 (no) Aminocycloheksyleterforbindelser og anvendelser derav
TW200848411A (en) Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
NO744397L (pl)
IL172334A (en) Benzazepine Derivatives, Pharmaceutical Preparation, Method of Manufacturing Pharmaceutical Preparation, Use of Pharmaceutical Manufacture Derivatives
EP1228052B1 (en) 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
KR20230003503A (ko) 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민
AU2004265243A1 (en) N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c receptor associated diseases
JP4159351B2 (ja) 5−ht3受容体及び神経細胞のニコチン性受容体に対するアンタゴニストとしての1−アミノ−アルキルシクロヘキサン
AU2001281861A1 (en) 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinicreceptor antagonists
US4173646A (en) Tricyclicdicarboximides
US4006233A (en) N-(pyrimidinyl)-tricyclo[3(or 4).2.2.02,4(or 5) ]-non (or dec)ene-dicarboximides
DE2227842C3 (de) Diphenylcyclopentane und diese enthaltende Arzneimittel
JPH05502659A (ja) 2,3,3a,4,5,6―ヘキサヒドロ―8―シクロヘキシル―1H―ピラジノ(3,2,1―j,k)カルバゾール塩酸塩、その化合物の調製方法及びそれに基づく抗うつ性医薬製剤
AT376659B (de) Verfahren zur herstellung von neuen substituierten 2-benzylpyrrolidinen
NO890519L (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
WO2010115124A2 (en) Compositions of cholinesterase inhibitors
JPH0473425B2 (pl)
CS247087B2 (en) Production method of new 1-(acetylamino)-2-aminopropanon

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees